title: Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta.
authors: Denis
authors: D
authors: Ouzan
authors: Guillaume
authors: G
authors: Pénaranda
authors: Hélène
authors: H
authors: Joly
authors: Philippe
authors: P
authors: Halfon
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D019701:Hepatitis D, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a